CN116036384A - Preparation method of self-oxygenated antibacterial filling and fixing material - Google Patents
Preparation method of self-oxygenated antibacterial filling and fixing material Download PDFInfo
- Publication number
- CN116036384A CN116036384A CN202310068228.3A CN202310068228A CN116036384A CN 116036384 A CN116036384 A CN 116036384A CN 202310068228 A CN202310068228 A CN 202310068228A CN 116036384 A CN116036384 A CN 116036384A
- Authority
- CN
- China
- Prior art keywords
- solution
- filling
- fixing material
- hydrogen peroxide
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医用材料制备技术领域,涉及一种自供氧抗菌填充固定材料的制备方法。The invention belongs to the technical field of preparation of biomedical materials, and relates to a preparation method of a self-oxygenation antibacterial filling and fixing material.
背景技术Background technique
当前,各种自然灾害导致的开放性创伤患者数量增加,虽然在后期治疗时得到了丰富的医疗技术支持,但在院前急救期仍然是采用传统夹板外固定为主,对于创伤内部起到固定作用效果甚微且固定效率低下,甚至导致创伤二次损伤或造成其他问题,进而加重伤情,存在一定短板,而急救恰对于创伤后期治疗尤为重要,因此,如何更好的对创伤进行院前急救,降低急救期产生副作用的概率,改善后期治疗效果,解决创伤院前急救技术所存在的问题是目前急需攻克的问题。创伤发生后,由于环境的原因容易造成创生部位细菌感染,如果不及时进行抗菌治疗会使得创伤部位发展成化脓性伤口,情况更严重者将会休克截肢,甚至细菌严重感染扩散引起死亡,所以材料需要具备抗菌效果,另外最重要的是患者在转运途中需要保证固定部位具有一定含量的氧气,避免填充固定后氧气含量缺少导致的细菌增殖能力加快以及正常细胞缺氧性死亡,所以,发展一种可以用于创伤部位内填充固定的自供氧抗菌材料成为解决上述问题的关键。At present, the number of patients with open trauma caused by various natural disasters is increasing. Although they have received rich medical technical support in the later stage of treatment, traditional splint external fixation is still mainly used in the pre-hospital emergency period to fix the wound internally. The effect is very small and the fixation efficiency is low, which may even lead to secondary trauma or other problems, and then aggravate the injury. There are certain shortcomings, and first aid is especially important for post-trauma treatment. Pre-emergency, reducing the probability of side effects during the first aid period, improving the effect of later treatment, and solving the problems of trauma pre-hospital first aid techniques are urgently needed to be overcome. After the trauma occurs, due to environmental reasons, it is easy to cause bacterial infection at the wound site. If antibacterial treatment is not carried out in time, the wound site will develop into a purulent wound. If the situation is more serious, it will be shocked and amputated, and even the spread of severe bacterial infection will cause death. Therefore, The material needs to have an antibacterial effect. In addition, the most important thing is that the patient needs to ensure that the fixed part has a certain amount of oxygen during the transfer, so as to avoid the accelerated bacterial proliferation and the anoxic death of normal cells caused by the lack of oxygen content after filling and fixing. Therefore, the development of a A self-oxygenated antibacterial material that can be used for filling and fixing wound sites becomes the key to solving the above problems.
中国发明专利《一种缓释氧气微球及其制备方法、使用方法以及在治疗糖尿病足和肿瘤疾病中的应用》(申请号202210868565.6,公开日2022.10.21,公开号CN 115212183A)公开了一种缓释氧气微球及其制备方法、使用方法以及在治疗糖尿病足和肿瘤疾病中的应用,包括内核以及包裹在内核外侧的外壳,内核包含溶有CaCl2和PVP的H2O2溶液,外壳包括水凝胶以及粘附在水凝胶表面的过氧化氢酶和干细胞,所述水凝胶采用海藻酸钠、琼脂糖、透明质酸(HA)、壳聚糖、卡拉胶(CRG)、结冷胶(GG)中一种,释放氧气的性能稳定、装载量高、流失率低,可有效解决氧气在释放过程中用量难以控制的缺点,从而在缺氧微环境中缓慢释放氧气,提高干细胞的治疗效果。但是,该释氧微球虽然具有氧气释放控制效果,但是存在初始小程度突释现象,容易造成细胞氧中毒。中国发明专利《一种缓控释氧微球及其制备方法和用途》(申请号201810174515.1,公开日2018.07.24,公开号CN 108310470 A)公开了一种缓控释氧微球及其制备方法和用途,所述的缓控释氧微球为明胶为基质的微球,在微球内部包含过氧化无机物颗粒,过氧化无机物选自CaO2、MgO2、NaCO3、SrO2、BaO2、K2O2、Na2O2。公开的缓控释氧缓释材料具有大小可控、释氧时间长、释氧时间可控、突释率低、地细胞毒性、低免疫源性、制备过程相对简单、易于工业化等优点,在骨缺损修复的临床应用中具有较大的应用前景,但是该微球仍然具有短暂的药物突释现象,容易在初始供氧阶段造成细胞氧中毒。The Chinese invention patent "A Slow-release Oxygen Microsphere and Its Preparation Method, Application Method and Application in the Treatment of Diabetic Foot and Tumor Diseases" (application number 202210868565.6, publication date 2022.10.21, publication number CN 115212183A) discloses a Slow-release oxygen microspheres and their preparation method, use method and application in the treatment of diabetic foot and tumor diseases, including an inner core and a shell wrapped outside the inner core, the inner core contains H 2 O 2 solution dissolved with CaCl 2 and PVP, and the outer shell Including hydrogel and catalase and stem cells adhered to the surface of the hydrogel, the hydrogel uses sodium alginate, agarose, hyaluronic acid (HA), chitosan, carrageenan (CRG), Gellan gum (GG), a kind of gellan gum (GG), has stable oxygen release performance, high loading capacity, and low loss rate, which can effectively solve the disadvantage that the amount of oxygen in the release process is difficult to control, thereby slowly releasing oxygen in an anoxic microenvironment and improving The therapeutic effect of stem cells. However, although the oxygen-releasing microspheres have the effect of controlling oxygen release, there is an initial small burst release phenomenon, which easily causes cellular oxygen poisoning. Chinese invention patent "A Slow and Controlled Oxygen Release Microsphere and Its Preparation Method and Application" (application number 201810174515.1, publication date 2018.07.24, publication number CN 108310470 A) discloses a slow and controlled oxygen release microsphere and its preparation method and purposes, the slow and controlled oxygen release microspheres are gelatin-based microspheres, containing peroxide inorganic particles inside the microspheres, and the peroxide inorganic substances are selected from CaO 2 , MgO 2 , NaCO 3 , SrO 2 , BaO 2. K 2 O 2 , Na 2 O 2 . The disclosed slow-controlled oxygen release material has the advantages of controllable size, long oxygen release time, controllable oxygen release time, low burst release rate, low cytotoxicity, low immunogenicity, relatively simple preparation process, and easy industrialization. The clinical application of bone defect repair has great application prospects, but the microspheres still have a short-term burst drug release phenomenon, which is easy to cause cellular oxygen poisoning in the initial oxygen supply stage.
由于突释所带来的负面作用例如局部浓度过高,后期释放浓度不足,不能维持稳定的治疗效果,因此设计一种具有精准零级释放动力学模型的氧气释放载体为避免突释带来的副作用具有一定的意义。另外为满足良好的抗菌效果,药物理想化释放也应满足零级释放模型以避免药物突释产生的副作用。因此,基于现阶段的急救需求,亟需制备一种理想化零级释放型供氧抗菌开放性创伤内部填充固定急救材料,具有巨大的临床应用价值。Due to the negative effects of burst release, such as high local concentration and insufficient release concentration in the later period, it is impossible to maintain a stable therapeutic effect. Therefore, an oxygen release carrier with an accurate zero-order release kinetic model was designed to avoid the negative effects of burst release. The side effects make sense. In addition, in order to meet the good antibacterial effect, the ideal drug release should also meet the zero-order release model to avoid side effects caused by drug burst release. Therefore, based on the current emergency needs, it is urgent to prepare an ideal zero-order release oxygen-supplying antibacterial open wound internal filling and fixing emergency material, which has great clinical application value.
发明内容Contents of the invention
本发明的目的是提供一种自供氧抗菌填充固定材料的制备方法,解决了现有技术在创伤院前急救时,因用于创伤部位内部填充固定急救材料不理想导致的抗感染治疗、改善以及急救效果不足的问题。The purpose of the present invention is to provide a preparation method of a self-oxygenated antibacterial filling and fixing material, which solves the problem of anti-infection treatment and improvement caused by the unsatisfactory filling and fixing first aid material used in the wound site during the pre-hospital first aid of trauma in the prior art. And the problem of insufficient first aid effect.
本发明所采用的技术方案是,一种自供氧抗菌填充固定材料的制备方法,按照以下步骤具体实施:The technical solution adopted in the present invention is a preparation method of a self-oxygenated antibacterial filling and fixing material, which is specifically implemented according to the following steps:
步骤1,配制双氧水溶液,将药物按照5~15mg/ml质量体积百分比溶解在双氧水溶液中,简称溶液A;配制聚乙二醇溶液,简称溶液B;配制过氧化氢酶溶液,简称溶液C;Step 1, preparing a hydrogen peroxide solution, dissolving the drug in the hydrogen peroxide solution according to the mass volume percentage of 5-15 mg/ml, referred to as solution A; preparing a polyethylene glycol solution, referred to as solution B; preparing a catalase solution, referred to as solution C;
步骤2,首先将蒙脱土加入溶液A中,超声均匀分散后,进行过氧化氢及药物负载搅拌,搅拌结束后抽滤,真空干燥;然后将干燥后的蒙脱土重新分散于溶液B中,进行PEG包覆搅拌,搅拌结束后抽滤,真空干燥;最后将干燥后的蒙脱土重新分散于溶液C中,进行过氧化氢酶的搭载搅拌,搅拌结束后抽滤,真空干燥;重复本步骤多次,得到载双氧水/抗生素零级释放载体;Step 2, first add montmorillonite to solution A, after ultrasonic dispersion, carry out stirring with hydrogen peroxide and drug loading, after the stirring is completed, suction filter, and vacuum dry; then redisperse the dried montmorillonite in solution B , carry out PEG coating and stirring, suction filtration after stirring, and vacuum drying; finally, redisperse the dried montmorillonite in solution C, carry out stirring with catalase, suction filtration after stirring, and vacuum drying; repeat This step is repeated multiple times to obtain a zero-order release carrier loaded with hydrogen peroxide/antibiotics;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO, and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚混合均匀,得到填充固定材料成分E;Step 4, uniformly mixing MMA, N,N-dimethyl-p-toluidine, and hydroquinone to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即成。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4, stir, and fill the open fracture site by injection, the filling and fixing material component D and the filling and fixing material component E After the reaction is over, it's done.
本发明的有益效果是,包括以下优点:The beneficial effects of the present invention include the following advantages:
1)以具有吸水作用的蒙脱土为基体,采用层层自组装技术将双氧水、抗生素、PEG以及过氧化氢酶负载于蒙拓土表面。首先,蒙脱土的吸水性可以保证材料在填充过程中吸收血液组织液进而膨胀,从而使PMMA材料膨胀,膨胀产生的压应力使填充更为密实并且对周围出血组织进行压迫止血,达到填充止血双重目的;其次,层层自组装技术依靠于动态氢键将所有物质进行复合,双氧水以及抗生素在依靠浓度差进行释放,双氧水在释放时经过氧化氢酶分解产生氧气,氧气的释放可以为创伤部位自供氧保证创伤部位氧气含量充足,预防多种细菌滋生,繁殖,并且能够使伤口局部保持干燥;另外,自供氧功能可以使组织细胞得到更充足的氧气,避免在固定期间细胞缺氧性死亡,同时抗生素的释放能够对创伤部位进行广谱抗菌,避免或者对创伤部位进行预防或抗菌治疗。1) Using montmorillonite with water absorption as the matrix, hydrogen peroxide, antibiotics, PEG and catalase are loaded on the surface of montmorillonite by layer-by-layer self-assembly technology. First of all, the water absorption of montmorillonite can ensure that the material absorbs blood tissue fluid and then expands during the filling process, so that the PMMA material expands, and the compressive stress generated by the expansion makes the filling more compact and compresses the surrounding bleeding tissue to stop bleeding, achieving dual filling and hemostasis. Purpose; secondly, the layer-by-layer self-assembly technology relies on dynamic hydrogen bonds to compound all substances. Hydrogen peroxide and antibiotics are released depending on the concentration difference. When hydrogen peroxide is released, it is decomposed by catalase to generate oxygen. Oxygen supply ensures sufficient oxygen content in the wound site, prevents the growth and reproduction of various bacteria, and keeps the wound part dry; in addition, the self-oxygen supply function can make tissue cells receive more sufficient oxygen and avoid cell hypoxic death during fixation , At the same time, the release of antibiotics can carry out broad-spectrum antibacterial on the wound site, avoiding or performing prophylactic or antibacterial treatment on the wound site.
2)所制备的氧气/抗生素释放载体是基于动态氢键制备的多层自组装体,双氧水以及抗生素在释放速率与层间的氢键崩解有关,同时利用PEG分子量作为崩解速率决定开关使得氢键的崩解受控,进而控制药物的释放,同时,PEG的崩解速率恒定,最终使氧气以及抗生素是释放呈零级释放且不受其他因素影响。2) The prepared oxygen/antibiotic release carrier is a multilayer self-assembly based on dynamic hydrogen bonds. The release rate of hydrogen peroxide and antibiotics is related to the disintegration of hydrogen bonds between layers. At the same time, the molecular weight of PEG is used as the disintegration rate decision switch to make The disintegration of hydrogen bonds is controlled, thereby controlling the release of drugs. At the same time, the disintegration rate of PEG is constant, and finally the release of oxygen and antibiotics is zero-order release and is not affected by other factors.
3)采用生物相容性良好的PMMA固定材料作为基体,一方面是因为其具有良好的生物相容性,在对创伤部位进行填充期间保证人体组织的安全性,其次PMMA材料具有一定的可塑性,可以根据创伤部位任意塑形,PMMA材料具有自固化性,固化后具有高的机械性能,在充分固定后可以保护填充部位,避免因转运途中的其他原因造成二次损伤。3) The PMMA fixation material with good biocompatibility is used as the matrix. On the one hand, it is because of its good biocompatibility, which ensures the safety of human tissue during the filling of the wound site. Secondly, the PMMA material has certain plasticity. It can be shaped arbitrarily according to the wounded part. The PMMA material is self-curing and has high mechanical properties after curing. After being fully fixed, it can protect the filling part and avoid secondary damage caused by other reasons during transportation.
具体实施方式Detailed ways
本发明的自供氧抗菌填充固定材料的制备方法,按照以下步骤具体实施:The preparation method of the self-oxygenation antibacterial filling and fixing material of the present invention is implemented according to the following steps:
步骤1,配制双氧水溶液,将药物按照5~15mg/ml质量体积百分比溶解在双氧水溶液中,简称溶液A;配制聚乙二醇(PEG)溶液,简称溶液B;配制过氧化氢酶溶液,简称溶液C;Step 1, prepare hydrogen peroxide solution, dissolve the drug in the hydrogen peroxide solution according to the mass volume percentage of 5-15 mg/ml, referred to as solution A; prepare polyethylene glycol (PEG) solution, referred to as solution B; prepare catalase solution, referred to as solution B; Solution C;
双氧水溶液的体积分数为20~40%,聚乙二醇(PEG)溶液的浓度为75~115mg/ml,过氧化氢酶溶液的浓度为100~400μg/ml;The volume fraction of the hydrogen peroxide solution is 20-40%, the concentration of the polyethylene glycol (PEG) solution is 75-115 mg/ml, and the concentration of the catalase solution is 100-400 μg/ml;
药物选用盐酸万古霉素、盐酸左氧氟沙星、盐酸四环素或头孢曲松钠中的一种;The drug is one of vancomycin hydrochloride, levofloxacin hydrochloride, tetracycline hydrochloride or ceftriaxone sodium;
PEG选用PEG2000、PEG4000、PEG6000、PEG8000或PEG10000中的一个。PEG selects one of PEG2000, PEG4000, PEG6000, PEG8000 or PEG10000.
步骤2,首先将蒙脱土加入溶液A中,超声均匀分散后,进行过氧化氢及药物负载搅拌,搅拌结束后抽滤,真空干燥;然后将一次干燥后的蒙脱土重新分散于溶液B中,进行PEG包覆搅拌,搅拌结束后抽滤,真空干燥;最后将二次干燥后的蒙脱土重新分散于溶液C中,进行过氧化氢酶的搭载搅拌,搅拌结束后抽滤,真空干燥;重复本步骤多次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2, first add montmorillonite to solution A, after ultrasonic dispersion, carry out stirring with hydrogen peroxide and drug loading, after stirring, filter with suction and vacuum dry; then redisperse the once-dried montmorillonite in solution B PEG-coated stirring, after the stirring, suction filtration, and vacuum drying; finally, the secondary dried montmorillonite was redispersed in solution C, carrying out stirring with catalase, after the stirring, suction filtration, vacuum drying Drying; repeat this step several times, and use the layer-by-layer self-assembly technology to obtain the hydrogen peroxide/antibiotic zero-order release carrier;
蒙脱土的质量为溶液A体积的20~40%,过氧化氢及药物负载搅拌的时间为1~2h,PEG包覆搅拌的时间为1~2h,过氧化氢酶搭载搅拌的时间为1~2h,重复循环次数为3~8次。The quality of montmorillonite is 20-40% of the volume of solution A, the time for hydrogen peroxide and drug loading and stirring is 1-2 hours, the time for PEG coating and stirring is 1-2 hours, and the time for carrying catalase is 1-2 hours. ~2h, the number of repeated cycles is 3~8 times.
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体混合均匀,得到急救用途的填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO, and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 to obtain the filling and fixing material component D for emergency use;
其中,PMMA粉体、引发剂BPO以及载双氧水/抗生素零级释放载体三者的质量比为49.95~69.85:0.05~0.15:30~50。Among them, the mass ratio of the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier is 49.95-69.85:0.05-0.15:30-50.
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚混合均匀,得到急救用途的填充固定材料成分E;Step 4, mixing MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly to obtain the filling and fixing material component E for emergency use;
其中,MMA、N,N-二甲基对甲苯胺、对苯二酚三者的质量比为96.5~99.5:0.3~3:0.1~0.5。Wherein, the mass ratio of MMA, N,N-dimethyl-p-toluidine and hydroquinone is 96.5-99.5:0.3-3:0.1-0.5.
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为1~2g/ml混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to a solid-liquid ratio of 1 to 2 g/ml, stir, and fill the open fracture site by injection. After the reaction between component D of the fixing material and component E of the filling and fixing material is completed, the wound site can be further fixed.
本发明自供氧抗菌填充固定材料的制备方法,首先采用动态氢键层层自组装技术,将双氧水、抗生素、PEG以及过氧化氢酶负载于蒙脱土上制备成零级释放载体,其次将PMMA粉体、引发剂BPO以及载双氧水/抗生素零级释放载体混合均匀,得到填充固定材料成分D,将MMA、N,N-二甲基对甲苯胺、对苯二酚混合均匀,得到填充固定材料成分E,最后将两种成分进行混合得到零级释放型供氧抗菌开放性骨折内部填充固定急救材料,注射填塞即可对开放性骨折进行充分填充,PMMA硬化后即可对填充部位进行固定。The preparation method of the self-oxygenation antibacterial filling and fixing material of the present invention first adopts the dynamic hydrogen bond layer-by-layer self-assembly technology to load hydrogen peroxide, antibiotics, PEG and catalase on montmorillonite to prepare a zero-order release carrier, and then PMMA powder, initiator BPO, and hydrogen peroxide/antibiotic zero-order release carrier are mixed evenly to obtain filling and fixing material component D, and MMA, N,N-dimethyl-p-toluidine, and hydroquinone are mixed evenly to get filling and fixing Material component E, and finally mix the two components to obtain a zero-order release oxygen-supplying antibacterial internal filling and fixing first aid material for open fractures. The open fracture can be fully filled by injection packing, and the filling part can be fixed after PMMA hardens .
实施例1Example 1
本发明自供氧抗菌填充固定材料的制备方法,具体过程为:The preparation method of the self-oxygen supply antibacterial filling and fixing material of the present invention, the specific process is:
步骤1,配制体积分数为20%的双氧水溶液,将药物按照5mg/ml质量体积百分比同时溶解在双氧水溶液中,简称溶液A;配制浓度为75mg/ml聚乙二醇(PEG)溶液,简称溶液B;配制浓度100μg/ml的过氧化氢酶溶液,简称溶液C;药物选用盐酸万古霉素;PEG为PEG2000;Step 1, prepare a hydrogen peroxide solution with a volume fraction of 20%, and dissolve the drug in the hydrogen peroxide solution at a mass volume percentage of 5 mg/ml at the same time, referred to as solution A; prepare a polyethylene glycol (PEG) solution with a concentration of 75 mg/ml, referred to as solution B; prepare a catalase solution with a concentration of 100 μg/ml, referred to as solution C; the drug is vancomycin hydrochloride; PEG is PEG2000;
步骤2,首先按溶液体积的20%(mg/ml),将一定质量的蒙脱土超声均匀分散于溶液A中,然后搅拌1h进行过氧化氢及药物负载,搅拌结束后抽滤,真空干燥;然后将一次干燥后的蒙脱土重新分散于溶液B中进行PEG包覆搅拌,搅拌时间为1h,搅拌结束后抽滤,真空干燥;最后将二次干燥后的蒙脱土重新分散于溶液C中进行过氧化氢酶的搭载,搅拌时间为1h,搅拌结束后抽滤,真空干燥;重复本步骤3次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2: First, according to 20% of the solution volume (mg/ml), ultrasonically disperse a certain mass of montmorillonite evenly in solution A, then stir for 1 hour to carry out hydrogen peroxide and drug loading, after the stirring is completed, suction filter and vacuum dry ; Then redisperse the once-dried montmorillonite in solution B for PEG coating and stirring, the stirring time is 1h, suction filter after the stirring, and vacuum-dry; finally, re-disperse the second-dried montmorillonite in the solution Carry out the carrying of catalase in C, the stirring time is 1h, suction filtration after stirring, and vacuum drying; repeat this step 3 times, utilize the layer-by-layer self-assembly technology to obtain the hydrogen peroxide/antibiotic zero-order release carrier;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体按照质量比49.95:0.05:50混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 evenly according to the mass ratio of 49.95:0.05:50 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚按质量比为96.5:3:0.5混合均匀,得到填充固定材料成分E;Step 4: Mix MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly in a mass ratio of 96.5:3:0.5 to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为1g/ml混合,搅拌,通过注射形式对开放性创伤部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to a solid-to-liquid ratio of 1 g/ml, stir, and fill the open wound site by injection, and the fixing material to be filled After component D reacts with component E of the filling and fixing material, the wound site can be further fixed.
实施例2Example 2
本发明自供氧抗菌填充固定材料的制备方法的具体过程为:The concrete process of the preparation method of self-oxygen supply antibacterial filling and fixing material of the present invention is:
步骤1,配制体积分数为40%的双氧水溶液,将药物按照15mg/ml质量体积百分比同时溶解在双氧水溶液中,简称溶液A;配制浓度为115mg/ml聚乙二醇(PEG)溶液,简称溶液B;配制浓度400μg/ml的过氧化氢酶溶液,简称溶液C;药物选用盐酸左氧氟沙星;PEG为PEG4000;Step 1, prepare a hydrogen peroxide solution with a volume fraction of 40%, and dissolve the drug in the hydrogen peroxide solution at a mass volume percentage of 15 mg/ml at the same time, referred to as solution A; prepare a polyethylene glycol (PEG) solution with a concentration of 115 mg/ml, referred to as solution B; prepare the catalase solution of concentration 400 μ g/ml, be called for short solution C; Medicine selects levofloxacin hydrochloride for use; PEG is PEG4000;
步骤2,按溶液体积的40%(mg/ml),将一定质量的蒙脱土超声均匀分散于溶液A中,然后搅拌2h进行过氧化氢及药物负载,搅拌结束后抽滤,真空干燥;然后将一次干燥后的蒙脱土重新分散于溶液B中进行PEG包覆搅拌,搅拌时间为2h,搅拌结束后抽滤,真空干燥;最后将二次干燥后的蒙脱土重新分散于溶液C中进行过氧化氢酶的搭载,搅拌时间为2h,搅拌结束后抽滤,真空干燥;重复本步骤8次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2, according to 40% (mg/ml) of the volume of the solution, ultrasonically disperse a certain mass of montmorillonite evenly in the solution A, then stir for 2 hours to carry out hydrogen peroxide and drug loading, after the stirring is completed, suction filter and vacuum dry; Then redisperse the once-dried montmorillonite in solution B for PEG-coating and stirring, the stirring time is 2h, suction filter after the stirring, and vacuum-dry; finally, re-disperse the second-dried montmorillonite in solution C Carry out the carrying of catalase in the medium, the stirring time is 2h, suction filtration after stirring, and vacuum drying; repeat this step 8 times, utilize the layer-by-layer self-assembly technology to obtain the hydrogen peroxide/antibiotic zero-order release carrier;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体按照质量比69.85:0.15:30混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 evenly according to the mass ratio of 69.85:0.15:30 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚按质量比为99.5:0.4:0.1混合均匀,得到填充固定材料成分E;Step 4: Mix MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly in a mass ratio of 99.5:0.4:0.1 to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为2g/ml混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to the solid-liquid ratio of 2 g/ml, stir, and fill the open fracture site by injection, and the fixing material to be filled After component D reacts with component E of the filling and fixing material, the wound site can be further fixed.
实施例3Example 3
本发明自供氧抗菌填充固定材料的制备方法的具体过程为:The concrete process of the preparation method of self-oxygen supply antibacterial filling and fixing material of the present invention is:
步骤1,配制体积分数为25%的双氧水溶液,将药物按照7.5mg/ml质量体积百分比同时溶解在双氧水溶液中,简称溶液A;配制浓度为85mg/ml聚乙二醇(PEG)溶液,简称溶液B;配制浓度200μg/ml的过氧化氢酶溶液,简称溶液C;药物选用盐酸四环素,PEG为PEG6000;Step 1, prepare a hydrogen peroxide solution with a volume fraction of 25%, and dissolve the drug in the hydrogen peroxide solution at a mass volume percentage of 7.5 mg/ml at the same time, referred to as solution A; prepare a polyethylene glycol (PEG) solution with a concentration of 85 mg/ml, referred to as Solution B; prepare a catalase solution with a concentration of 200 μg/ml, referred to as solution C; the drug is tetracycline hydrochloride, and the PEG is PEG6000;
步骤2,按溶液体积的25%(mg/ml),将一定质量的蒙脱土超声均匀分散于溶液A中,然后搅拌2h进行过氧化氢及药物负载,搅拌结束后抽滤,真空干燥,然后将一次干燥后的蒙脱土重新分散于溶液B中进行PEG包覆搅拌,搅拌时间为2h,搅拌结束后抽滤,真空干燥,最后将二次干燥后的蒙脱土重新分散于溶液C中进行过氧化氢酶的搭载,搅拌时间为2h,搅拌结束后抽滤,真空干燥;重复本步骤4次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2, according to 25% (mg/ml) of the volume of the solution, ultrasonically disperse a certain mass of montmorillonite in the solution A, and then stir for 2 hours to carry out hydrogen peroxide and drug loading, after the stirring is completed, suction filtration, vacuum drying, Then redisperse the once-dried montmorillonite in solution B for PEG coating and stirring, the stirring time is 2h, suction filter after the stirring, and vacuum-dry, and finally re-disperse the second-dried montmorillonite in solution C Carry out the carrying of catalase in the medium, the stirring time is 2h, suction filtration after stirring, and vacuum drying; repeat this step 4 times, utilize layer-by-layer self-assembly technology to obtain carrying hydrogen peroxide/antibiotics zero-order release carrier;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体按照质量比64.85:0.15:35混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 evenly according to the mass ratio of 64.85:0.15:35 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚按质量比为98.5:1:0.5混合均匀,得到填充固定材料成分E;Step 4: Mix MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly in a mass ratio of 98.5:1:0.5 to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为1.5g/ml混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to a solid-to-liquid ratio of 1.5 g/ml, stir, and fill the open fracture site by injection, to be filled and fixed After the reaction between the material component D and the filling and fixing material component E is completed, the wound site can be further fixed.
实施例4Example 4
本发明自供氧抗菌填充固定材料的制备方法的具体过程为:The concrete process of the preparation method of self-oxygen supply antibacterial filling and fixing material of the present invention is:
步骤1,配制体积分数为30%的双氧水溶液,将药物按照10mg/ml质量体积百分比同时溶解在双氧水溶液中,简称溶液A;配制浓度为115mg/ml聚乙二醇(PEG)溶液,简称溶液B;配制浓度300μg/ml的过氧化氢酶溶液,简称溶液C;药物选用头孢曲松钠,PEG为PEG8000;Step 1, prepare a hydrogen peroxide solution with a volume fraction of 30%, and dissolve the drug in the hydrogen peroxide solution at a mass volume percentage of 10 mg/ml at the same time, referred to as solution A; prepare a polyethylene glycol (PEG) solution with a concentration of 115 mg/ml, referred to as solution B; prepare a catalase solution with a concentration of 300 μg/ml, referred to as solution C; the drug is ceftriaxone sodium, and the PEG is PEG8000;
步骤2,按溶液体积的30%(mg/ml),将一定质量的蒙脱土超声均匀分散于溶液A中,然后搅拌1.5h进行过氧化氢及药物负载,搅拌结束后抽滤,真空干燥;然后将一次干燥后的蒙脱土重新分散于溶液B中进行PEG包覆搅拌,搅拌时间为2h,搅拌结束后抽滤,真空干燥;最后将二次干燥后的蒙脱土重新分散于溶液C中进行过氧化氢酶的搭载,搅拌时间为1.5h,搅拌结束后抽滤,真空干燥;重复本步骤5次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2: According to 30% (mg/ml) of the solution volume, ultrasonically disperse a certain mass of montmorillonite in solution A, then stir for 1.5 hours to carry out hydrogen peroxide and drug loading, after the stirring is completed, suction filter and vacuum dry ; Then redisperse the once-dried montmorillonite in solution B for PEG coating and stirring, the stirring time is 2h, suction filter after stirring, and dry in vacuum; finally re-disperse the second-dried montmorillonite in the solution Carry out the carrying of catalase in C, the stirring time is 1.5h, suction filtration after stirring, and vacuum drying; repeat this step 5 times, use the layer-by-layer self-assembly technology to obtain the hydrogen peroxide/antibiotic zero-order release carrier;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体按照质量比62.95:0.05:37混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 evenly according to the mass ratio of 62.95:0.05:37 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚按质量比为97.5:2.1:0.4混合均匀,得到填充固定材料成分E;Step 4: Mix MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly in a mass ratio of 97.5:2.1:0.4 to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为2g/ml混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to the solid-liquid ratio of 2 g/ml, stir, and fill the open fracture site by injection, and the fixing material to be filled After component D reacts with component E of the filling and fixing material, the wound site can be further fixed.
实施例5Example 5
本发明自供氧抗菌填充固定材料的制备方法的具体过程为:The concrete process of the preparation method of self-oxygen supply antibacterial filling and fixing material of the present invention is:
步骤1,配制体积分数为35%的双氧水溶液,将药物按照15mg/ml质量体积百分比同时溶解在双氧水溶液中,简称溶液A,配制浓度为115mg/ml聚乙二醇(PEG)溶液,简称溶液B;配制浓度350μg/ml的过氧化氢酶溶液,简称溶液C;药物为盐酸万古霉素,PEG为PEG10000;Step 1, prepare a hydrogen peroxide solution with a volume fraction of 35%, and dissolve the drug in the hydrogen peroxide solution at a mass volume percentage of 15 mg/ml at the same time, referred to as solution A, and prepare a polyethylene glycol (PEG) solution with a concentration of 115 mg/ml, referred to as solution B; prepare a catalase solution with a concentration of 350 μg/ml, referred to as solution C; the drug is vancomycin hydrochloride, and the PEG is PEG10000;
步骤2,按溶液体积的40%(mg/ml),将一定质量的蒙脱土超声均匀分散于溶液A中,然后搅拌2h进行过氧化氢及药物负载,搅拌结束后抽滤,真空干燥;然后将一次干燥后的蒙脱土重新分散于溶液B中进行PEG包覆搅拌,搅拌时间为2h,搅拌结束后抽滤,真空干燥;最后将二次干燥后的蒙脱土重新分散于溶液C中进行过氧化氢酶的搭载,搅拌时间为1h,搅拌结束后抽滤,真空干燥;重复本步骤7次,利用层层自组装技术得到载双氧水/抗生素零级释放载体;Step 2, according to 40% (mg/ml) of the volume of the solution, ultrasonically disperse a certain mass of montmorillonite evenly in the solution A, then stir for 2 hours to carry out hydrogen peroxide and drug loading, after the stirring is completed, suction filter and vacuum dry; Then redisperse the once-dried montmorillonite in solution B for PEG-coating and stirring, the stirring time is 2h, suction filter after the stirring, and vacuum-dry; finally, re-disperse the second-dried montmorillonite in solution C Carry out the carrying of catalase, the stirring time is 1h, suction filtration after stirring, and vacuum drying; repeat this step 7 times, use the layer-by-layer self-assembly technology to obtain the hydrogen peroxide/antibiotic zero-order release carrier;
步骤3,将PMMA粉体、引发剂BPO以及步骤2得到的载双氧水/抗生素零级释放载体按照质量比59.85:0.15:40混合均匀,得到填充固定材料成分D;Step 3, mix the PMMA powder, the initiator BPO and the hydrogen peroxide/antibiotic zero-order release carrier obtained in step 2 evenly according to the mass ratio of 59.85:0.15:40 to obtain the filling and fixing material component D;
步骤4,将MMA、N,N-二甲基对甲苯胺、对苯二酚按质量比为96.5~99.5:0.3~3:0.1~0.5混合均匀,得到填充固定材料成分E;Step 4: Mix MMA, N,N-dimethyl-p-toluidine, and hydroquinone evenly in a mass ratio of 96.5-99.5:0.3-3:0.1-0.5 to obtain the filling and fixing material component E;
步骤5,将步骤3得到的填充固定材料成分D与步骤4得到的填充固定材料成分E按照固液比为1g/ml混合,搅拌,通过注射形式对开放性骨折部位进行填充,待填充固定材料成分D与填充固定材料成分E反应结束后,即可对创伤部位进行进一步的固定。Step 5, mix the filling and fixing material component D obtained in step 3 with the filling and fixing material component E obtained in step 4 according to the solid-liquid ratio of 1g/ml, stir, and fill the open fracture site by injection, and the fixing material to be filled After component D reacts with component E of the filling and fixing material, the wound site can be further fixed.
经实验证明,本发明制备方法得到的自供氧抗菌填充固定材料在模拟人体环境下的氧气释放以及抗生素的释放遵循零级释放动力学,避免因药物以及氧气突释导致的副作用,同时经临床实验使用后,材料的固定性、感染预防及抗菌治疗均表现良好。Experiments have proved that the oxygen release and antibiotic release of the self-oxygenated antibacterial filling and fixing material obtained by the preparation method of the present invention follow zero-order release kinetics in a simulated human environment, avoiding side effects caused by sudden release of drugs and oxygen. After the experimental use, the immobilization, infection prevention and antibacterial treatment of the material all performed well.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310068228.3A CN116036384B (en) | 2023-02-06 | 2023-02-06 | Preparation method of self-oxygen-supply antibacterial filling and fixing material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310068228.3A CN116036384B (en) | 2023-02-06 | 2023-02-06 | Preparation method of self-oxygen-supply antibacterial filling and fixing material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116036384A true CN116036384A (en) | 2023-05-02 |
| CN116036384B CN116036384B (en) | 2024-07-02 |
Family
ID=86116144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310068228.3A Active CN116036384B (en) | 2023-02-06 | 2023-02-06 | Preparation method of self-oxygen-supply antibacterial filling and fixing material |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116036384B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816566A (en) * | 2012-11-16 | 2014-05-28 | 赫罗伊斯医疗有限责任公司 | Antiseptic polymethylmethacrylate bone cement |
| US20160220737A1 (en) * | 2013-05-28 | 2016-08-04 | The Johns Hopkins University | Oxygen-charged implantable medical devices for and methods of local delivery of oxygen via outgassing |
| CN114917248A (en) * | 2022-05-27 | 2022-08-19 | 中山大学附属第三医院 | Intracellular self-supplied hydrogen peroxide nanomaterial, preparation method and application thereof |
| CN115212183A (en) * | 2022-07-22 | 2022-10-21 | 瑞安市人民医院(瑞安市人民医院医疗服务集团瑞安市妇幼保健院瑞安市红十字医院) | Sustained-release oxygen microspheres, preparation method and use method thereof, and application of sustained-release oxygen microspheres in treatment of diabetic foot and tumor diseases |
| CN115231582A (en) * | 2022-07-19 | 2022-10-25 | 西安交通大学 | A kind of two-dimensional montmorillonite large-scale nanosheet exfoliation method |
-
2023
- 2023-02-06 CN CN202310068228.3A patent/CN116036384B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816566A (en) * | 2012-11-16 | 2014-05-28 | 赫罗伊斯医疗有限责任公司 | Antiseptic polymethylmethacrylate bone cement |
| US20160220737A1 (en) * | 2013-05-28 | 2016-08-04 | The Johns Hopkins University | Oxygen-charged implantable medical devices for and methods of local delivery of oxygen via outgassing |
| CN114917248A (en) * | 2022-05-27 | 2022-08-19 | 中山大学附属第三医院 | Intracellular self-supplied hydrogen peroxide nanomaterial, preparation method and application thereof |
| CN115231582A (en) * | 2022-07-19 | 2022-10-25 | 西安交通大学 | A kind of two-dimensional montmorillonite large-scale nanosheet exfoliation method |
| CN115212183A (en) * | 2022-07-22 | 2022-10-21 | 瑞安市人民医院(瑞安市人民医院医疗服务集团瑞安市妇幼保健院瑞安市红十字医院) | Sustained-release oxygen microspheres, preparation method and use method thereof, and application of sustained-release oxygen microspheres in treatment of diabetic foot and tumor diseases |
Non-Patent Citations (2)
| Title |
|---|
| LEI CHEN等: "Sequential release of double drug (graded distribution) loaded gelatin microspheres/PMMA bone cement", 《JOURNAL OF MATERIALS CHEMISTRY B》, vol. 9, no. 2, 23 November 2020 (2020-11-23), pages 508 - 522 * |
| 刘涉江等: "CPC/CaO2氧缓释复合材料的制备及其释氧性能探讨", 《环境工程学报》, vol. 4, no. 5, 31 May 2010 (2010-05-31), pages 971 - 974 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116036384B (en) | 2024-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3882858A (en) | Surgical synthetic-resin material and method of treating osteomyelitis | |
| US5968999A (en) | Bone cement compositions | |
| US6689375B1 (en) | Resorbable bone implant material and method for producing the same | |
| RU2176525C2 (en) | Surgical implant material or bandage material releasing medication preparation | |
| CN101564556B (en) | Preparation method of multistage drug release carrier compounded by gelatin microspheres and calcium phosphate cement | |
| CN108379666B (en) | A kind of gelatin microsphere/magnesium phosphate-based bone cement drug sustained-release carrier and preparation method thereof | |
| JP2006110370A (en) | Specific biodegradable biomedical implant | |
| US5972384A (en) | Use of biologically active glass as a drug delivery system | |
| HK1041803A1 (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
| JP2013509963A (en) | Fragmented hydrogel | |
| WO2007095005A1 (en) | Agents and devices for providing blood clotting functions to wounds | |
| JP2003530363A (en) | Injectable bone mineral replacement material | |
| CN105056298B (en) | A kind of porous calcium phosphate microsphere material with surface macropore, preparation method and application | |
| CN111317861B (en) | Expansion acrylic acid bone cement capable of controlling release of antibiotics and preparation method thereof | |
| CN110327497A (en) | A kind of injection gel and preparation method thereof containing microballoon | |
| CN111729131A (en) | Intelligent controlled-release medicine-carrying bone cement and preparation method and application thereof | |
| CN101536987A (en) | Sodium alginate microballoon vein suppository containing hemangioma-resisting medicant, preparation method and application thereof | |
| CN115177779B (en) | Biological glue and preparation method and application thereof | |
| CN1446589A (en) | Medicine controlled functional cement with calcium phosphate being as framework and its preparation method | |
| CN116212100A (en) | Self-repairing anti-oxidation hydrogel dressing for treating oral wounds and preparation method thereof | |
| JPS626522B2 (en) | ||
| CN116036384B (en) | Preparation method of self-oxygen-supply antibacterial filling and fixing material | |
| CN101905033A (en) | Drug microcapsule composite calcium-deficient calcium phosphate bone cement and its use, preparation method and application | |
| CN102247599A (en) | Slow release system for borate bioglass carried with antibiotic and preparation method thereof | |
| CN115068691B (en) | Injectable bioactive hydrogel and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |